Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer.
Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer. Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer. Moneycontrol Latest News Read More